You are here

severe asthma

Amgen Highlights New COPD, Asthma and Vasculitis Research at ATS 2024

BioSpace

Wed, 05/1/24 - 09:31 am

AstraZeneca Expands Fasenra’s Label to Younger Children with Severe Asthma

BioSpace

Fri, 04/12/24 - 11:15 am

eosinophilic asthma

Aiolos Bio launches with ex-Gyroscope CEO at the helm, nearly $250M to advance severe asthma med

Fierce Biotech

Tue, 10/24/23 - 09:48 am

AstraZeneca, Amgen's asthma launch Tezspire picks up backing from England's NICE

Fierce Pharma

Wed, 03/29/23 - 09:58 am

Sanofi, Regeneron team with Broadway actor for digital severe asthma program

Medical Marketing and Media

Wed, 10/19/22 - 10:54 pm

pharma marketing

Sanofi’s asthma therapy shows consistent safety profile in Phase III trial

Clinical Trials Arena

Tue, 09/6/22 - 05:06 pm

clinical trials

GSK looks to stand out in the severe asthma space with at-home injections for kids 6 to 11 years old

Endpoints

Mon, 01/24/22 - 11:34 pm

AstraZeneca and Amgen’s asthma biologic approved in the US

Biopharma Reporter

Mon, 12/20/21 - 11:08 am

Aiming to uproot the market for asthma attacks, AstraZeneca and Avillion tout two PhIII wins for inhaled combo drug

Endpoints

Thu, 09/9/21 - 10:58 am

clinical trials

Amgen, AstraZeneca's tezepelumab is looking for a slice of blockbuster asthma market dominated by Sanofi's Dupixent

Fierce Biotech

Thu, 05/13/21 - 10:57 am

AstraZeneca, Amgen Breathing Easier with Optimistic Phase III Asthma Drug Results

BioSpace

Mon, 03/1/21 - 11:17 am

clinical trials

Amgen, AstraZeneca's tezepelumab hits goal in asthma phase 3

Fierce Pharma

Tue, 11/10/20 - 10:41 am

clinical trials

Upcoming events – Novartis’s asthma Zeal and Alnylam's lumasiran test

EP Vantage

Sat, 10/19/19 - 01:36 pm

Primary Hyperoxaluria

GlaxoSmithKline's Nucala cuts severe asthma attacks in 'reassuring' interim real-world data

Fierce Pharma

Tue, 10/1/19 - 10:05 am

real world data

AstraZeneca's Fasenra offers severe asthma patients 2 years of benefits: analysis

Fierce Pharma

Mon, 05/20/19 - 10:12 am

clinical trials

Vectura’s Severe Asthma Treatment Fails in Phase III Trial

BioSpace

Mon, 11/26/18 - 12:40 pm

drug-device combos

AstraZeneca’s respiratory group scores FDA OK for a blockbuster severe asthma drug

Endpoints

Wed, 11/15/17 - 08:38 am

AstraZeneca asthma drug tralokinumab disappoints again

Yahoo/Reuters

Wed, 11/1/17 - 09:37 am

AstraZeneca's new benralizumab helps severe asthma patients cut back on steroids

Fierce Pharma

Mon, 05/22/17 - 07:44 pm

Blockbuster cancer drug shows surprising promise in treating severe asthma

Stat

Thu, 05/18/17 - 12:07 am

Pages